ARTA recommends filing of raps vs FDA official

THE Anti-Red Tape Authority (ARTA) has endorsed to the Office of the Ombudsman the filing of charges against the head of the Food and Drug Administration-Center for Drug Regulation and Research (FDA-CDRR) for sitting on hundreds of Automatic Renewal (AR) drug applications.

In its motu propio disposition dated June 8, 2021 addressed to Ombudsman Samuel Martires, ARTA recommended 412 counts of failure to render government services within the prescribed processing time under Section 21 (e) of the Republic Act (RA) 11032 or the "Ease of Doing Business and Efficient Government Service Delivery Act of 2018" against FDA-CDRR Director Jesusa Joyce Cirunay.